Yin T - Search Results

1

Progression of malignant pleural effusion during the early stage of gefitinib treatment in advanced EGFR-mutant lung adenocarcinoma involving complex driver gene mutations.

Liu N, Yu M, Yin T, Jiang Y, Liao X, Tang J, Li Y, Qin D, Li D, Wang Y. Liu N, et al. Among authors: yin t. Signal Transduct Target Ther. 2020 May 27;5(1):63. doi: 10.1038/s41392-020-0161-7. Signal Transduct Target Ther. 2020. PMID: 32457345 Free PMC article. No abstract available.

2

Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.

He S, Yin T, Li D, Gao X, Wan Y, Ma X, Ye T, Guo F, Sun J, Lin Z, Wang Y. He S, et al. Among authors: yin t. J Transl Med. 2013 Aug 12;11:186. doi: 10.1186/1479-5876-11-186. J Transl Med. 2013. PMID: 23937717 Free PMC article.

3

Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3.

Tang J, Guo F, Du Y, Liu X, Qin Q, Liu X, Yin T, Jiang L, Wang Y. Tang J, et al. Among authors: yin t. Int J Oncol. 2015 May;46(5):2083-95. doi: 10.3892/ijo.2015.2898. Epub 2015 Feb 17. Int J Oncol. 2015. PMID: 25695284

4

Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.

Yin T, Wang G, He S, Shen G, Su C, Zhang Y, Wei X, Ye T, Li L, Yang S, Li D, Guo F, Mo Z, Wan Y, Ai P, Zhou X, Liu Y, Wang Y, Wei Y. Yin T, et al. J Biol Chem. 2016 Dec 23;291(52):26750-26761. doi: 10.1074/jbc.M116.753236. Epub 2016 Oct 18. J Biol Chem. 2016. PMID: 27756837 Free PMC article.

5

Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model.

Yin T, He S, Wang Y. Yin T, et al. Mol Med Rep. 2015 Sep;12(3):3515-3520. doi: 10.3892/mmr.2015.3885. Epub 2015 Jun 3. Mol Med Rep. 2015. PMID: 26043701

6

In vitro and in vivo assessment of high-dose vitamin C against murine tumors.

Wang G, Yin T, Wang Y. Wang G, et al. Among authors: yin t. Exp Ther Med. 2016 Nov;12(5):3058-3062. doi: 10.3892/etm.2016.3707. Epub 2016 Sep 16. Exp Ther Med. 2016. PMID: 27882116 Free PMC article.

7

Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention.

Zhang B, Li X, Yin T, Qin D, Chen Y, Ma Q, Shu P, Wang Y. Zhang B, et al. Among authors: yin t. J Oncol. 2022 Jan 18;2022:4259205. doi: 10.1155/2022/4259205. eCollection 2022. J Oncol. 2022. PMID: 35087588 Free PMC article. Review.

8

Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.

Yin T, Wang G, Ye T, Wang Y. Yin T, et al. Sci Rep. 2016 Jan 18;6:19534. doi: 10.1038/srep19534. Sci Rep. 2016. PMID: 26777116 Free PMC article.

9

Extravascular red blood cells and hemoglobin promote tumor growth and therapeutic resistance as endogenous danger signals.

Yin T, He S, Liu X, Jiang W, Ye T, Lin Z, Sang Y, Su C, Wan Y, Shen G, Ma X, Yu M, Guo F, Liu Y, Li L, Hu Q, Wang Y, Wei Y. Yin T, et al. J Immunol. 2015 Jan 1;194(1):429-37. doi: 10.4049/jimmunol.1400643. Epub 2014 Nov 26. J Immunol. 2015. PMID: 25429070

10

HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model.

Yin T, He S, Shen G, Wang Y. Yin T, et al. Oncol Res. 2014;22(3):139-45. doi: 10.3727/096504014X13983417587366. Oncol Res. 2014. PMID: 26168132 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,680 results

Search Page

Filters